bioMerieux UK launches Staphylococcus assay:
This article was originally published in Clinica
bioMerieux UK has launched a latex agglutination assay for Staphylococcus aureus. The assay, called Slidex Staph Plus, offers 97.6% sensitivity to methicillin resistant and 98.5% sensitivity to methicillin resistant and methicillin sensitive strains combined. Slidex Staph Plus detects clumping factor, the body's immune response to infection as well as protein A and peripheral and capsular antigens. Positive samples form thick agglutinates within 30 seconds.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.